Ablynx NV
Belgium
CMS manufacturer 100000226809
General payments
$0
Research payments
$420,566
Ownership & investment interest
$0
Through program year 2021, Ablynx NV reported paying $0 in general payments and $420,566 in research payments to U.S. physicians, teaching hospitals and other recipients.
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $43,931 | 15 |
| 2020 | Research | $139,420 | 30 |
| 2019 | Research | $237,215 | 62 |
Breakdown
Records
107 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.